Mark McCune, MD
Dermatology · Overland Park, KSNPI 1871607267
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,842 of the $4,768 with a category attached, or 80.6%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,668 and has fallen 99.1% since, to $15 in 2025.
Across 190 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim Pharma GmbH & Co.kg$1K
- AbbVie$825
- Organogenesis Inc.$402
- LEO Pharma Inc.$395
- Novartis$352
- Pfizer$290
- plus $1K from 20 others
Across 627 payments — averaging $3147.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$553K
- Eli Lilly$268K
- AbbVie$234K
- Pfizer$178K
- Incyte Corporation$159K
- Amgen$123K
- plus $459K from 15 others
What the payments were for
- Travel & lodging$85018%
- Food & beverage$3,84281%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim Pharma GmbH & Co.kg | 5 | $1,014 |
| AbbVie(2 entities) | 42 | $825 |
| Organogenesis Inc. | 5 | $402 |
| LEO Pharma Inc. | 21 | $395 |
| Novartis | 20 | $352 |
| Pfizer | 20 | $290 |
| Sun Pharmaceutical Industries Inc. | 9 | $233 |
| Genentech USA, Inc. | 11 | $179 |
| UCB, Inc. | 5 | $153 |
| Incyte Corporation | 6 | $131 |
| Amgen | 5 | $121 |
| E.r. Squibb & Sons, L.L.C. | 6 | $103 |
| Almirall LLC | 4 | $89 |
| Dermavant Sciences, Inc. | 5 | $89 |
| Sanofi | 4 | $80 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $57 |
| Galderma Laboratories, L.p. | 4 | $52 |
| Johnson & Johnson | 3 | $39 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $11 |
| Bristol Myers Squibb | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puraply Antimicrobial$338
- Erivedge$129
- BOTOX COSMETIC$107
- Winlevi$107
How this compares
$4,768 in reported general payments places this provider in the 75th percentile of 82 dermatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 162 | $435 |
| Doxycycline Monohydrate | 38 | $259 |
| Prednisone | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Overland Park
- David KaplanOverland Park$489K
- Meena SinghOverland Park$181K
- Reba SuriOverland Park$7K
- Lauren Kyle TkachukOverland Park$6K
- Megan LentOverland Park$5K
- Jeffery GravesOverland Park$3K
- Carol FouldsOverland Park$3K
- Stephen MatlockOverland Park$3K
- Mitchell GibbonsOverland Park$2K
- Lisa MorrisOverland Park$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.